Jinichi Mori

971 total citations
43 papers, 554 citations indexed

About

Jinichi Mori is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jinichi Mori has authored 43 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 11 papers in Molecular Biology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jinichi Mori's work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (14 papers) and Acute Lymphoblastic Leukemia research (11 papers). Jinichi Mori is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (14 papers) and Acute Lymphoblastic Leukemia research (11 papers). Jinichi Mori collaborates with scholars based in Japan, United States and United Kingdom. Jinichi Mori's co-authors include Koichi Matsuda, Chizu Tanikawa, Yuki Funauchi, Yusuke Nakamura, Paulisally Hau Yi Lo, Hisashi Sakamaki, Minoru Ando, Masaharu Tsubokura, Tetsuya Tanimoto and Yohei Miyagi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Jinichi Mori

40 papers receiving 549 citations

Peers

Jinichi Mori
Jie Peng China
Benjamin A. Derman United States
Ankur R. Parikh United States
Wahid T. Hanna United States
Caroline Berube United States
Jinichi Mori
Citations per year, relative to Jinichi Mori Jinichi Mori (= 1×) peers Caitlyn Vlasschaert

Countries citing papers authored by Jinichi Mori

Since Specialization
Citations

This map shows the geographic impact of Jinichi Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinichi Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinichi Mori more than expected).

Fields of papers citing papers by Jinichi Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinichi Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinichi Mori. The network helps show where Jinichi Mori may publish in the future.

Co-authorship network of co-authors of Jinichi Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Jinichi Mori. A scholar is included among the top collaborators of Jinichi Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinichi Mori. Jinichi Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mori, Jinichi, et al.. (2025). Assessment of chromatin remodeling of acute myeloid leukemia cells treated with gilteritinib: a case report. Journal of Medical Case Reports. 19(1). 153–153.
2.
Mori, Jinichi, Naoki Shingai, Takeshi Kobayashi, & Noriko Doki. (2023). Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation. SHILAP Revista de lepidopterología. 16(1). 640–644. 2 indexed citations
3.
Sawada, Takahiro, et al.. (2022). Antagonistic action of a synthetic androgen ligand mediated by chromatin remodeling in a human prostate cancer cell line. Biochemical and Biophysical Research Communications. 612. 110–118. 5 indexed citations
4.
Hayakawa, Akira, et al.. (2022). Skeletal and gene-regulatory functions of nuclear sex steroid hormone receptors. Journal of Bone and Mineral Metabolism. 40(3). 361–374. 4 indexed citations
5.
Hayakawa, Akira, Takahiro Sawada, Tomohiro Kurokawa, et al.. (2021). Transcriptional Regulation of 25-Hydroxyvitamin D-24-Hydroxylase (CYP24A1) by Calcemic Factors in Keratinocytes. Journal of Nutritional Science and Vitaminology. 67(6). 424–428. 7 indexed citations
6.
Mori, Jinichi, Shizuo Kaji, H. Kawai, et al.. (2020). Assessment of dysplasia in bone marrow smear with convolutional neural network. Scientific Reports. 10(1). 14734–14734. 34 indexed citations
7.
8.
Mori, Jinichi, Kumi Oshima, & Tetsuya Tanimoto. (2020). Cat Rearing: A Potential Risk of Fulminant Sepsis Caused by <b><i>Capnocytophaga canimorsus</i></b> in a Hemodialysis Patient. Case Reports in Nephrology and Dialysis. 10(2). 51–56. 2 indexed citations
9.
Mori, Jinichi, Kumi Oshima, Tetsuya Tanimoto, et al.. (2020). Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney disease. International Journal of Hematology. 112(1). 115–117. 9 indexed citations
10.
Yanada, Masamitsu, Akiyoshi Takami, Shohei Mizuno, et al.. (2019). Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan. International Journal of Hematology. 111(1). 93–102. 14 indexed citations
11.
Tanimoto, Tetsuya, Tomohiro Morita, Yoshitaka Nishikawa, et al.. (2018). A model-based estimation of inter-prefectural migration of physicians within Japan and associated factors. Medicine. 97(22). e10878–e10878. 1 indexed citations
12.
Tanikawa, Chizu, Yaozhong Zhang, Yusuke Tsuda, et al.. (2017). The Transcriptional Landscape of p53 Signalling Pathway. EBioMedicine. 20. 109–119. 56 indexed citations
13.
Mori, Jinichi, Chizu Tanikawa, Naomi Ohnishi, et al.. (2017). EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis. Neoplasia. 19(3). 185–195. 13 indexed citations
14.
Koguchi, Tomoyuki, Chizu Tanikawa, Jinichi Mori, Yoshiyuki Kojima, & Koichi Matsuda. (2016). Regulation of myo-inositol biosynthesis by p53-ISYNA1 pathway. International Journal of Oncology. 48(6). 2415–2424. 37 indexed citations
15.
Mori, Jinichi, Tetsuya Tanimoto, Yuji Miura, & Masahiro Kami. (2015). Fatal adverse drug reactions of anticancer drugs detected by all-case post-marketing surveillance in Japan. Japanese Journal of Clinical Oncology. 45(6). 588–94. 2 indexed citations
16.
Mori, Jinichi, Ken Ishiyama, Takuhiro Yamaguchi, et al.. (2015). Outcomes of allogeneic hematopoietic cell transplantation in patients with biphenotypic acute leukemia. Annals of Hematology. 95(2). 295–300. 6 indexed citations
17.
Akiyama, Junichi, Shigeaki Kato, Masaharu Tsubokura, et al.. (2015). Minimal Internal Radiation Exposure in Residents Living South of the Fukushima Daiichi Nuclear Power Plant Disaster. PLoS ONE. 10(10). e0140482–e0140482. 6 indexed citations
18.
Mori, Jinichi, Masaharu Tsubokura, Amina Sugimoto, et al.. (2013). Increased incidence of dog-bite injuries after the Fukushima nuclear accident. Preventive Medicine. 57(4). 363–365. 11 indexed citations
19.
Tsubokura, Masaharu, Jinichi Mori, Tetsuya Tanimoto, & Tomoyoshi Oikawa. (2012). A Dog Bite Injury after the Fukushima Nuclear Accident. Internal Medicine. 51(17). 2493–2493. 2 indexed citations
20.
Tanimoto, Tetsuya, et al.. (2012). Differences in drug approval processes of 3 regulatory agencies: a case study of gemtuzumab ozogamicin. Investigational New Drugs. 31(2). 473–478. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026